Putative Biomarkers of Response to Treatment in Breast Cancer Patients: A Pilot Assay.

Autor: Rico MJ; a Institute of Experimental Genetics, School of Medicine, National University of Rosario , Rosario , Argentina.; b National Scientific and Technological Research Council (CONICET) , Rosario , Argentina., Perroud HA; a Institute of Experimental Genetics, School of Medicine, National University of Rosario , Rosario , Argentina.; b National Scientific and Technological Research Council (CONICET) , Rosario , Argentina., Herrera C; a Institute of Experimental Genetics, School of Medicine, National University of Rosario , Rosario , Argentina., Alasino CM; c Institute of Oncology of Rosario , Rosario , Argentina., Roggero EA; a Institute of Experimental Genetics, School of Medicine, National University of Rosario , Rosario , Argentina., Pezzotto SM; d Institute of Immunology, School of Medical Sciences, National University of Rosario , Rosario , Argentina.; e National University of Rosario Research Council (CIUNR) , Rosario , Argentina., Nocito AL; f Department of Pathological Anatomy and Physiology , School of Medical Sciences, National University of Rosario , Rosario , Argentina., Rozados VR; a Institute of Experimental Genetics, School of Medicine, National University of Rosario , Rosario , Argentina., Scharovsky OG; a Institute of Experimental Genetics, School of Medicine, National University of Rosario , Rosario , Argentina.; b National Scientific and Technological Research Council (CONICET) , Rosario , Argentina.; e National University of Rosario Research Council (CIUNR) , Rosario , Argentina.

Publikováno v: Cancer investigation [Cancer Invest] 2017 Jul 03; Vol. 35 (6), pp. 377-385. Date of Electronic Publication: 2017 Apr 20.

Quality of life in patients with metastatic breast cancer treated with metronomic chemotherapy.

Autor: Perroud HA; Experimental Oncology Section, Institute of Experimental Genetics, School of Medical Sciences, National University of Rosario, Rosario, Argentina.; National Scientific & Technological Research Council (CONICET), Rosario, Argentina., Alasino CM; Institute of Oncology of Rosario, Rosario, Argentina., Rico MJ; Experimental Oncology Section, Institute of Experimental Genetics, School of Medical Sciences, National University of Rosario, Rosario, Argentina.; National Scientific & Technological Research Council (CONICET), Rosario, Argentina., Queralt F; Institute of Oncology of Rosario, Rosario, Argentina., Pezzotto SM; Institute of Immunology, School of Medical Sciences, National University of Rosario, Rosario, Argentina.; Research Council of the National University of Rosario (CIUNR), Rosario, Argentina., Rozados VR; Experimental Oncology Section, Institute of Experimental Genetics, School of Medical Sciences, National University of Rosario, Rosario, Argentina., Scharovsky OG; Experimental Oncology Section, Institute of Experimental Genetics, School of Medical Sciences, National University of Rosario, Rosario, Argentina.; Research Council of the National University of Rosario (CIUNR), Rosario, Argentina.

Publikováno v: Future oncology (London, England) [Future Oncol] 2016 May; Vol. 12 (10), pp. 1233-42. Date of Electronic Publication: 2016 Mar 07.

Association between baseline VEGF/sVEGFR-2 and VEGF/TSP-1 ratios and response to metronomic chemotherapy using cyclophosphamide and celecoxib in patients with advanced breast cancer.

Autor: Perroud HA; Institute of Experimental Genetics, School of Medical Sciences, National University of Rosario, Rosario, Argentina., Rico MJ, Alasino CM, Pezzotto SM, Rozados VR, Scharovsky OG

Publikováno v: Indian journal of cancer [Indian J Cancer] 2013 Apr-Jun; Vol. 50 (2), pp. 115-21.